Cancer

Lisata Therapeutics to Report Third Quarter 2025 Financial Results and Provide a Business Update on Thursday, November 6, 2025

BASKING RIDGE, N.J., Oct. 30, 2025 (GLOBE NEWSWIRE) -- Lisata Therapeutics, Inc. (Nasdaq: LSTA) (“Lisata” or the “Company”), a clinical-stage…

4 months ago

BioNxt Reports “Readiness to Grant” Patent Notification from the Eurasian Patent Organization

VANCOUVER, BC / ACCESS Newswire / October 30, 2025 / BioNxt Solutions Inc. ("BioNxt" or the "Company") (CSE:BNXT)(OTCQB:BNXTF)(FSE:BXT), a bioscience…

4 months ago

Eminent Physician-Scientist Dr. Jonathan D. Licht to Serve as Next President and Chief Scientific Officer of Van Andel Institute

GRAND RAPIDS, Mich., Oct. 29, 2025 /PRNewswire/ -- Van Andel Institute, a leading research organization based in Grand Rapids, Michigan, has…

4 months ago

Lilly announces more than $1.2 billion investment in Puerto Rico facility to boost oral medicine manufacturing capacity in the United States

Company plans to create 100 manufacturing jobs and up to 1,000 construction jobs INDIANAPOLIS, Oct. 29, 2025 /PRNewswire/ -- Eli…

4 months ago

Redefining the future of transplant medicine at VCU Health

How nationally ranked Hume-Lee Transplant Center is giving more patients a second chance through innovation. RICHMOND, Va., Oct. 29, 2025 /PRNewswire/…

4 months ago

Caris Data Validates TET2 Clonal Hematopoiesis as a Biomarker for Enhanced Immunotherapy Response

IRVING, Texas, Oct. 29, 2025 /PRNewswire/ -- Caris Life Sciences® (NASDAQ: CAI), a leading, patient-centric, next-generation AI TechBio company and precision…

4 months ago

CustoMED Announces $6M Funding to Scale AI-Powered 3D Printed Solutions for Orthopedic Surgery

Surgeon-First Platform Transforms Medical Imaging into Real-Time, Patient-Specific Surgical Guides and Implants for New Standard in Precision Surgery RAMAT GAN,…

4 months ago

Treating Measles Infection: Nanoviricides CEO Dr Anil Diwan Interviewed by Steve Darling from Proactive

SHELTON, CONNECTICUT / ACCESS Newswire / October 29, 2025 / NanoViricides, Inc., a publicly traded company (NYSE Amer.:NNVC) (the "Company"),…

4 months ago